Market Scenario:
During the last few years, there is a significant increase in the demand for cardiovascular devices. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths. According to the findings from the WHO, in 2015, 82% of the total deaths occurred were in the low- and middle-income countries. Additionally, according to the Centers for Disease Control and Prevention (2015), over 630,000 Americans die from heart disease each year, which accounts for 1 in every 4 deaths. Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of the market. However, the cardiovascular devices manufacturers need to follow the rules stated by FDA and have to compliance with policies and procedures related to the manufacturing of these devices. Strict regulatory rules and high cost of the devices may slow the growth of the market during the forecast period.
The cardiovascular application market is expected to grow at a CAGR of 7.24% during the forecast period and is estimated to reach USD 36730.5 million by 2023.
Get Exclusive Sample Report @https://www.marketresearchfuture.com/sample_request/5669
Segments:
The global cardiovascular application market has been segmented on the basis of devices and end users.
On the basis of the devices, the global cardiovascular application market is segmented into the cardiac pacemaker, defibrillators, monitors, and others. The cardiac monitors are further segmented into resting ECG, ECG monitors, holter monitors, implantable loop recorder, and others. The cardiac pacemaker are further segmented into implantable cardiac pacemaker, and external cardiac pacemaker.
On the basis of the end users, the market is segmented into cardiac care centers, ambulatory centers & home care, academic institutes, and others.
Intended Audience:
• Cardiovascular Products Manufacturers
• Cardiovascular Products Providers
• Medical Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors
Key Findings:
The global cardiovascular application market is growing at a growth rate of 7.24% during the forecast period 2017-2023. Increasing prevalence of the cardiovascular diseases, increasing geriatric population, and technological advances are some of the major factors responsible for market growth
The market is categorized into number of different cardiovascular devices. The category of cardiac monitors holds the major share in the market.
General Electric Company, Koninklijke Philips N.V, Abbott, and Medtronic are some of the prominent market players in the cardiovascular application market
Regional Analysis:
The Americas accounted for the major share of the market owing to the presence of a huge population of patients suffering from cardiovascular diseases, high healthcare expenditure, well-developed technology, and the presence of the leading players. Furthermore, rising government support for the development of the advanced devices and well-developed healthcare sector has boosted the growth of the cardiovascular application market in the Americas.
Asia Pacific is the fastest growing cardiovascular application market. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool is driving the growth of the market in this region. The Middle East & Africa holds the least share of the market owing to the presence of poor and slow developing countries, especially, in the African region. The major driving factors for the growth of the Middle East & African cardiovascular application market are increasing aging population and increasing number of diabetic and cardiovascular patients.
Key players in the global cardiovascular application market:
Some of the major players in this market are Abbott (U.S.), General Electric Company (U.S.), Medtronic (Ireland), Boston Scientific Corporation (U.S.), KONINKLIJKE PHILIPS N.V. (The Netherlands), Terumo (Japan), Stryker Corporation (U.S.), Edwards Lifesciences (U.S.), Allergan Inc. (U.S.), Smith & Nephew plc (U.K), CR Bard Inc. (U.S.), Sonova Holdings (Switzerland), and Dragerwerk AG & Co. KGa (Germany)
Get Your Customized Report @https://www.marketresearchfuture.com/reports/type-2-diabetes-mellitus-treatment-market-5669
Table of Content:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC Continued…!
Get Discount @https://www.marketresearchfuture.com/check-discount/5669
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]